| Lung Cancer Treatments and Mutations | Lifetime | 125 | CN 4 | 99.63 |
| Lung Cancer Diagnosis and Treatment | Lifetime | 122 | CN 4 | 99.57 |
| Lung Cancer Research Studies | Lifetime | 126 | CN 4 | 99.43 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 249 | CN 9 | 99.39 |
| Colorectal Cancer Treatments and Studies | Lifetime | 211 | CN 5 | 99.25 |
| Gastric Cancer Management and Outcomes | Lifetime | 878 | CN 33 | 98.33 |
| Cancer Diagnosis and Treatment | Lifetime | 600 | CN 8 | 97.13 |
| Cancer therapeutics and mechanisms | Lifetime | 661 | CN 16 | 96.75 |
| Metastasis and carcinoma case studies | Lifetime | 876 | CN 66 | 94.84 |
| Lung Cancer Diagnosis and Treatment | 2021-2025 | 2 | CN 2 | 99.95 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 18 | CN 1 | 99.91 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 8 | CN 2 | 99.96 |
| Lung Cancer Research Studies | 2021-2025 | 12 | CN 4 | 99.89 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 19 | CN 2 | 99.73 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 68 | CN 13 | 99.18 |
| Cancer Genomics and Diagnostics | 2021-2025 | 137 | CN 4 | 98.93 |
| Peptidase Inhibition and Analysis | 2021-2025 | 202 | CN 44 | 95.53 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 48 | CN 3 | 92.36 |
| Cancer therapeutics and mechanisms | 2021-2025 | 93 | CN 10 | 93.34 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 588 | CN 69 | 95.82 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 786 | CN 234 | 95.33 |
| HER2/EGFR in Cancer Research | 2021-2025 | 209 | CN 23 | 96.70 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 339 | CN 69 | 94.49 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 326 | CN 26 | 93.55 |
| Metastasis and carcinoma case studies | 2021-2025 | 245 | CN 55 | 90.36 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 742 | CN 329 | 88.19 |
| Cancer Diagnosis and Treatment | 2021-2025 | 409 | CN 38 | 83.29 |
| Cancer Research and Treatments | 2021-2025 | 689 | CN 285 | 81.65 |
| Cancer Mechanisms and Therapy | 2021-2025 | 985 | CN 438 | 71.25 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 888 | CN 106 | 38.08 |
